Hyeon-Cheol Gwon: Clinical Trials

3 trials sponsored by Hyeon-Cheol Gwon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Hyeon-Cheol Gwon: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent
BioMimeTM Stent, Ultimaster® Stent - Ischemic Heart Disease
UnknownHyeon-Cheol Gwon20002016-04-012018-02-09
Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
Ticagrelor, Clopidogrel, Morphine Sulfate - ST-Segment Elevation Myocardial Infarction
Phase 2UnknownHyeon-Cheol Gwon1002012-09-012016-07-06
Korean Coronary Bifurcation Stenting (COBIS) Registry II
Coronary Bifurcation Lesion
CompletedHyeon-Cheol Gwon28732011-01-012013-01-10

Conditions studied

Dysequilibrium syndrome (1)  ·  Myocardial Ischemia (1)  ·  ST Elevation Myocardial Infarction (1)

Interventions

Clopidogrel (1)  ·  Morphine (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  Ticagrelor (1)

Countries

South Korea (3)

Top investigators

Hyeon Cheol Gwon (1)

Results publications

PMID 23954335, PMID 24529936, PMID 26315732, PMID 28373244, PMID 28427585, PMID 30006330, PMID 30891962, PMID 34514841, PMID 37565964